•
ON
ONCO
Onconetix, Inc. Common Stock
polygonPHARMACEUTICAL PREPARATIONS
--
Price Chart
Market Cap
2.49M
Volume
1.04M
52W High
$88.40
52W Low
$1.37
Open
$1.73
Prev Close
$1.60
Day Range
1.51 - 1.76
About Onconetix, Inc. Common Stock
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.
Latest News
Onconetix and Ocuvex Therapeutics announce execution of definitive merger agreement
Benzinga•Jul 16
Why Tellurian Shares Are Trading Higher By Around 65%; Here Are 20 Stocks Moving Premarket - Benzinga
Benzinga•Jul 22
Onconetix Announces Closing of Warrant Exercise for $1.11 Million Gross Proceeds - GlobeNewswire
GlobeNewswire Inc.•Jul 15
Onconetix Announces Appointment of Seasoned Biotech Executives Dr. Ajit Singh and Dr. Thomas Meier to Its Board of Directors
GlobeNewswire Inc.•Feb 13
Why Fortinet Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket
Benzinga•Feb 7
Why Intel Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Benzinga•Jan 26
US Stocks Mixed; Core PCE Prices Rise In December
Benzinga•Jan 26
Why Tellurian Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket
Benzinga•Jan 26